Habitual Regular Coffee Consumption and Arterial Stiffness: Data From the 3rd Pamela Survey.

IF 3.2 3区医学 Q2 PERIPHERAL VASCULAR DISEASE

American Journal of Hypertension Pub Date : 2024-09-16 DOI:10.1093/ajh/hpae072

Raffaella Dell'Oro, Fosca Quarti-Trevano, Rita Facchetti, Cesare Cuspidi, Giuseppe Mancia, Guido Grassi

{"title":"Habitual Regular Coffee Consumption and Arterial Stiffness: Data From the 3rd Pamela Survey.","authors":"Raffaella Dell'Oro, Fosca Quarti-Trevano, Rita Facchetti, Cesare Cuspidi, Giuseppe Mancia, Guido Grassi","doi":"10.1093/ajh/hpae072","DOIUrl":null,"url":null,"abstract":"Background: We evaluated whether chronic coffee consumption affects arterial stiffness, assessed by cardio-ankle vascular index (CAVI).Methods: In 514 subjects, aged 66.6 ± 9.9 years (mean ± SD), recruited in the 3rd follow-up of the PAMELA study, subdivided into 3 groups according to the daily intake of regular coffee (0, 1-2, and ≥3 cups/day), we measured CAVI and clinic, ambulatory blood pressure (BP), and other variables.Results: The 3 groups displayed similar age, gender, metabolic, and renal profile. Clinic and ambulatory BPs were similar in the 3 groups, this being the case for CAVI (0 cup: 9.1 ± 1.8, 1-2 cups: 9.5 ± 2.3, and ≥3 cups: 9.2 ± 2.1 m/s, P = NS). No significant gender difference in CAVI and in participants under antihypertensive treatment was detected.Conclusions: Our data show that chronic coffee consumption leaves unaffected arterial stiffness in the general population, this being the case in subgroups. The neutral vascular impact of coffee may favor the absence of any significant BP effect of habitual coffee intake.","PeriodicalId":7578,"journal":{"name":"American Journal of Hypertension","volume":" ","pages":"755-758"},"PeriodicalIF":3.2000,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Hypertension","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ajh/hpae072","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}

引用次数: 0

Abstract

Background: We evaluated whether chronic coffee consumption affects arterial stiffness, assessed by cardio-ankle vascular index (CAVI).

Methods: In 514 subjects, aged 66.6 ± 9.9 years (mean ± SD), recruited in the 3rd follow-up of the PAMELA study, subdivided into 3 groups according to the daily intake of regular coffee (0, 1-2, and ≥3 cups/day), we measured CAVI and clinic, ambulatory blood pressure (BP), and other variables.

Results: The 3 groups displayed similar age, gender, metabolic, and renal profile. Clinic and ambulatory BPs were similar in the 3 groups, this being the case for CAVI (0 cup: 9.1 ± 1.8, 1-2 cups: 9.5 ± 2.3, and ≥3 cups: 9.2 ± 2.1 m/s, P = NS). No significant gender difference in CAVI and in participants under antihypertensive treatment was detected.

Conclusions: Our data show that chronic coffee consumption leaves unaffected arterial stiffness in the general population, this being the case in subgroups. The neutral vascular impact of coffee may favor the absence of any significant BP effect of habitual coffee intake.

查看原文本刊更多论文

习惯性常饮咖啡与动脉硬化--来自第三次帕梅拉调查的数据。

背景：我们评估了长期饮用咖啡是否会影响动脉僵化（用心血管指数评估）：我们评估了长期饮用咖啡是否会影响动脉僵化，动脉僵化可通过心踝关节血管指数（CAVI）进行评估：在 PAMELA 研究的第三次随访中，我们招募了 514 名年龄为 66.6±9.9 岁（平均值±SD）的受试者，根据每日普通咖啡摄入量（0 杯、1-2 杯和≥3 杯/天）分为 3 组，测量了 CAVI 和门诊、门诊血压（BP）及其他变量：结果：三组患者的年龄、性别、代谢和肾脏状况相似。3 组患者的门诊血压和动态血压相似，CAVI 也是如此（0 杯：9.1±1.8，1-2 杯：9.5±2.3，≥3 杯：9.2±2.1 米/秒，P=NS）。结论：我们的数据显示，长期饮用咖啡不会影响普通人群的动脉僵化，在亚群体中也是如此。咖啡对血管的影响是中性的，这可能是因为习惯性饮用咖啡对血压没有明显影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Journal of Hypertension 医学-外周血管病

CiteScore

6.90

自引率

6.20%

发文量

144

审稿时长

3-8 weeks

期刊介绍： The American Journal of Hypertension is a monthly, peer-reviewed journal that provides a forum for scientific inquiry of the highest standards in the field of hypertension and related cardiovascular disease. The journal publishes high-quality original research and review articles on basic sciences, molecular biology, clinical and experimental hypertension, cardiology, epidemiology, pediatric hypertension, endocrinology, neurophysiology, and nephrology.